JAZZ Financial Facts
Selling, general and administrative: 124.37MTotal operating expenses: 237.93M
See Full Income Statement
See Full Balance Sheet
Jazz Pharmaceuticals, Inc. (JAZZ) Earnings
|
Expand Research on JAZZ
| Next EPS Date | 5/1/24 | EPS Growth Rate | +6.3% |
|---|---|---|---|
| Average EPS % Beat Rate | -2.6% | Revenue Growth Rate | +7.1% |
| Average % Move 1-Wk after EPS | -2.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/1/24  |
Q124 | N/A | $4.20 | N/A | N/A | $955.95M | = | N/A | N/A | ||
| 2/28/24 | Q423 | $5.02 | $5.18 | -$0.16 | $1.01B | $1.01B | = |  | | Details | |
| 11/8/23 | Q323 | $4.84 | $4.93 | -$0.09 | $972M | $969.02M | = | | | Details | |
| 8/9/23 | Q223 | $4.51 | $4.45 | +$0.06 | $957.32M | $941.99M | = | | | Details | |
| 5/10/23 | Q123 | $3.95 | $4.24 | -$0.29 | $892.8M | $896.9M | = | | | Details | |
| 3/1/23 | Q422 | -$0.07 | $4.51 | -$4.58 | $972.13M | $975.18M | = | | | Details | |
| 11/9/22 | Q322 | $5.17 | $4.66 | +$0.51 | $940.65M | $939.97M |  |
| | Details | |
| 8/3/22 |
Q222 | $4.30 | $4.20 | +$0.10 | $932.9M | $902.46M | |
| | Details |
